Skip to main navigation Skip to search Skip to main content

Retraction: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus plus Interference in the IDO-1 Pathway (ACS Nano (2018) 12:11 (11041−11061) DOI: 10.1021/acsnano.8b05189)

  • Jianqin Lu
  • , Xiangsheng Liu
  • , Yu Pei Liao
  • , Xiang Wang
  • , Ayman Ahmed
  • , Wen Jiang
  • , Ying Ji
  • , Huan Meng
  • , Andre E. Nel

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Authors Xiangsheng Liu, Yu-Pei Liao, Xiang Wang, AymanAhmed, Ying Ji, Huan Meng, Andre E. Nel, and the Editor retract this work due to the inability to reproduce the claimed nanocarrier in the 4T1 breast cancer model. The authors suggest that the lysophosphatidylcholine prodrug has detergent-like properties that may disrupt the lipid bilayer. However, based on the inability to reproduce this nanocarrier, the authors retract the work, although the first author disagrees with the retraction. The original article was published on October 16, 2018 and retracted on May 21, 2021.

Original languageEnglish (US)
Pages (from-to)10735
Number of pages1
JournalACS Nano
Volume15
Issue number6
DOIs
StatePublished - Jun 22 2021

ASJC Scopus subject areas

  • General Materials Science
  • General Engineering
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Retraction: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus plus Interference in the IDO-1 Pathway (ACS Nano (2018) 12:11 (11041−11061) DOI: 10.1021/acsnano.8b05189)'. Together they form a unique fingerprint.

Cite this